These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16724314)

  • 1. Management of febrile neutropenia in pediatric oncology patients: a Canadian survey.
    Boragina M; Patel H; Reiter S; Dougherty G
    Pediatr Blood Cancer; 2007 May; 48(5):521-6. PubMed ID: 16724314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving concepts of management of febrile neutropenia in children with cancer.
    Orudjev E; Lange BJ
    Med Pediatr Oncol; 2002 Aug; 39(2):77-85. PubMed ID: 12116054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM; Herrera L; Sandler ES; Buchanan GR
    Cancer; 2000 Apr; 88(7):1710-4. PubMed ID: 10738231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
    Hodgson-Viden H; Grundy PE; Robinson JL
    BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient therapy for febrile neutropenia.
    Innes H; Marshall E
    Curr Opin Oncol; 2007 Jul; 19(4):294-8. PubMed ID: 17545790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
    Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient management of febrile neutropenia: time to revise the present treatment strategy.
    Carstensen M; Sørensen JB
    J Support Oncol; 2008; 6(5):199-208. PubMed ID: 18551855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in management of low-risk febrile neutropenia.
    Teuffel O; Sung L
    Curr Opin Pediatr; 2012 Feb; 24(1):40-5. PubMed ID: 22037219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency department waiting times for patients with cancer with febrile neutropenia: a pilot study.
    Nirenberg A; Mulhearn L; Lin S; Larson E
    Oncol Nurs Forum; 2004 Jul; 31(4):711-5. PubMed ID: 15252427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to treatment of the febrile cancer patient with low-risk neutropenia.
    Buchanan GR
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):919-35. PubMed ID: 8226566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
    Sung L; Feldman BM; Schwamborn G; Paczesny D; Cochrane A; Greenberg ML; Maloney AM; Hendershot EI; Naqvi A; Barrera M; Llewellyn-Thomas HA
    J Clin Oncol; 2004 Oct; 22(19):3922-9. PubMed ID: 15459214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
    Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial therapy of febrile neutropenia--current developments].
    Karthaus M; Cornely OA; Südhoff T; Meran J
    Wien Med Wochenschr; 2001; 151(3-4):66-72. PubMed ID: 11789421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Febrile neutropenia in the child with cancer. Current concepts about risk assessment and selective management].
    Santolaya ME
    Rev Med Chil; 2001 Dec; 129(12):1449-54. PubMed ID: 12080883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Febrile neutropenia at the emergency department of a cancer hospital].
    Debey C; Meert AP; Berghmans T; Thomas JM; Sculier JP
    Rev Med Brux; 2011; 32(2):74-82. PubMed ID: 21688591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
    J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.